Celecoxib vs naproxen

by KN Theken 2024sensitive or allergic to celecoxib, naproxen, aspirin, or other NSAIDs, or had used NSAIDs Celecoxib vs. Placebo: p 0.05. Naproxen vs

The primary outcome, incidence of cardiovascular death, myocardial infarction, or stroke, occurred in 2.3% of the celecoxib group vs. 2.7% of the ibuprofen group vs. 2.5% of the naproxen group (hazard ratio [HR] 0.85, p noninferiority 0.001 for celecoxib vs. ibuprofen; HR 0.93, p noninferiority 0.001 for celecoxib vs. naproxen; HR 1.08, p

Pairwise Comparison. Celecoxib vs. Naproxen. Celecoxib vs. Ibuprofen Ibuprofen vs. Naproxen. HR (95% CI). 0.93 (0.76, 1.13). 0.86 (0.70, 1.04).

by ND Yeomans 2024 Cited by 61Modified intention-to-treat populationa. Celecoxib vs Ibuprofen, Celecoxib vs Naproxen, Ibuprofen vs Naproxen Mechanism of action of

Of note, at Month 4, clinic SBP increased by 5.2 1.41 mmHg in the ibuprofen group, by 3.2 1.41 in the naproxen group and by 1.0 1.41 mmHg in celecoxib patients; (P = 0.007 for the ibuprofen vs. celecoxib comparison and P = 0.17 for the celecoxib vs. naproxen comparison).

Celecoxib vs. Naproxen, Celecoxib vs. Ibuprofen, Ibuprofen vs. Naproxen CELEBREX, diclofenac, or ibuprofen treatment groups. The cumulative rates in

For patients who did not titrate, P-values for mean change in 24-h SBP were 0.002, 0.51, 0.04 for celecoxib vs. ibuprofen, celecoxib vs. naproxen, and naproxen vs. ibuprofen respectively. Open in a separate window

Warfarin, aspirin, and other NSAIDs such as ibuprofen, naproxen, and celecoxib. Oxycodone vs. Hydrocodone for

The primary outcome, incidence of cardiovascular death, myocardial infarction, or stroke, occurred in 2.3% of the celecoxib group vs. 2.7% of the ibuprofen group vs. 2.5% of the naproxen group (hazard ratio [HR] 0.85, p noninferiority 0.001 for celecoxib vs. ibuprofen; HR 0.93, p noninferiority 0.001 for celecoxib vs. naproxen; HR 1.08, p